130 related articles for article (PubMed ID: 38097403)
1. Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts.
Hemmi T; Yusa K; Ishikawa S; Takano H; Fukuda M; Iino M
Br J Oral Maxillofac Surg; 2024 Jan; 62(1):63-70. PubMed ID: 38097403
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
[TBL] [Abstract][Full Text] [Related]
3. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
Scheper MA; Badros A; Chaisuparat R; Cullen KJ; Meiller TF
Br J Haematol; 2009 Mar; 144(5):667-76. PubMed ID: 19036117
[TBL] [Abstract][Full Text] [Related]
4. Zoledronate treatment exerts sex-independent effects on bone and dental physicochemical properties in mice jaw necrosis.
Lima-Verde MEQ; de Queiroz Rodrigues MI; Vieira BR; Lima-Verde Neto FTG; Agressott EVH; de Sousa FB; Paschoal AR; de Barros Silva PG; Sousa FB; Mota MRL; Alves APNN
J Bone Miner Metab; 2023 Nov; 41(6):760-771. PubMed ID: 37673837
[TBL] [Abstract][Full Text] [Related]
5. Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis.
Cui Y; Zhang W; Yang P; Zhu S; Luo S; Li M
Free Radic Biol Med; 2023 Sep; 206():33-49. PubMed ID: 37364692
[TBL] [Abstract][Full Text] [Related]
6. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy.
Tamari T; Elimelech R; Cohen G; Cohen T; Doppelt O; Eskander-Hashoul L; Zigdon-Giladi H
Sci Rep; 2019 Dec; 9(1):18896. PubMed ID: 31827217
[TBL] [Abstract][Full Text] [Related]
8. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
Anitua E; Zalduendo M; Troya M; Orive G
Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
[TBL] [Abstract][Full Text] [Related]
9. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
Cozin M; Pinker BM; Solemani K; Zuniga JM; Dadaian SC; Cremers S; Landesberg R; Raghavan S
J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
[TBL] [Abstract][Full Text] [Related]
10. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
11. Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid.
Steller D; Herbst N; Pries R; Juhl D; Hakim SG
Sci Rep; 2019 Jun; 9(1):8310. PubMed ID: 31165745
[TBL] [Abstract][Full Text] [Related]
12. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
Soundia A; Hadaya D; Chau Y; Gkouveris I; Bezouglaia O; Dry S; Pirih F; Aghaloo T; Tetradis S
Bone; 2021 Jul; 148():115945. PubMed ID: 33836308
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid suppresses transforming growth factor-β-induced fibrogenesis by human gingival fibroblasts.
Komatsu Y; Ibi M; Chosa N; Kyakumoto S; Kamo M; Shibata T; Sugiyama Y; Ishisaki A
Int J Mol Med; 2016 Jul; 38(1):139-47. PubMed ID: 27176567
[TBL] [Abstract][Full Text] [Related]
14. Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
Support Care Cancer; 2022 Mar; 30(3):2341-2348. PubMed ID: 34738163
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Tanaka Y; Aung KT; Ono M; Mikai A; Dang AT; Hara ES; Tosa I; Ishibashi K; Ono-Kimura A; Nawachi K; Kuboki T; Oohashi T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884630
[TBL] [Abstract][Full Text] [Related]
17. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid.
Mozzati M; Martinasso G; Maggiora M; Scoletta M; Zambelli M; Carossa S; Oraldi M; Muzio G; Canuto RA
Clin Oral Investig; 2013 May; 17(4):1259-66. PubMed ID: 22864527
[TBL] [Abstract][Full Text] [Related]
18. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.
Guirguis RH; Tan LP; Hicks RM; Hasan A; Duong TD; Hu X; Hng JYS; Hadi MH; Owuama HC; Matthyssen T; McCullough M; Canfora F; Paolini R; Celentano A
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371553
[TBL] [Abstract][Full Text] [Related]
20. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
